Description
Founded in 1999, Smilegate Investment is a venture capital firm based in Seoul, South Korea. The firm seeks to invest in disruptive technology companies with a focus on healthcare & biotechnology, information & communications technology, environment & life, and entertainment sectors across South Korea.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
RECO (Environmental Services (B2B)) | 24-Jan-2023 | Early Stage VC | 0000 | Environmental Services (B2B) | Generating Revenue | |
00000000000 (00000 | 17-Jan-2023 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
0000000000 (000000 | 17-Jan-2023 | 00000 00000 | 00.00 | Clinics/Outpatient Services | Generating Revenue | |
0000000.00 | 02-Jan-2023 | 00000 00000 | 00.000 | Distributors (Healthcare) | Generating Revenue | 000 000000-0000 |
0000000 | 31-Dec-2022 | 00000 00000 | 000.00 | Entertainment Software | Generating Revenue | |
0000 (00000 000 00 | 27-Dec-2022 | 00000 00000 | Elder and Disabled Care | Generating Revenue | 000 00000 00.0 | |
0000000000 | 30-Nov-2022 | 00000 00000 | Biotechnology | Clinical Trials - Phase 1 | ||
00 00 0000 | 29-Nov-2022 | 00000 00000 | 00.000 | Other Services (B2C Non-Financial) | Generating Revenue | |
VtoV | 11-Nov-2022 | Early Stage VC | 00.00 | Application Software | Startup | |
PranaQ | 04-Nov-2022 | Seed Round | 00.000 | Monitoring Equipment | Generating Revenue |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
3D Medicines | 15-Dec-2022 | IPO | 00000 |
00000 00000000 | 01-Aug-2022 | 000000000 00000000 | |
000000 | 14-Jul-2022 | 000 | 000.00 |
000000 | 20-Jun-2022 | 000000000000000000 | |
00000 000 | 08-Jun-2022 | 0000000 000000 | 00000 |
0000000000 | 28-May-2022 | 000 00 00000000 | |
0000 | 03-Mar-2022 | 000 | 000.00 |
00 00000 | 02-Feb-2022 | 0000000000 | |
Good T Cells | 26-Jul-2021 | Out of Business | |
VSI (Industrial Supplies and Parts) | 01-Jul-2021 | Secondary Transaction - Private |
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Ki-moon Nam | Chief Executive Officer | 0 | Seoul, South Korea | ||
Ku Young-Kwon | President | 0 | Seoul, South Korea | ||
Inwoo Kang | General Manager, Investments | Seoul, South Korea | |||
Jiyeon Lee | General Manager, Investments | Seoul, South Korea | |||
Kim Seung-Pil | General Manager, Investments | Seoul, South Korea |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
KB Investment | 12 | 0 | 0 |
![]() |
![]() |
IMM Investment | 00 | 0 |
![]() |
![]() |
|
DSC Investment | 0 | 0 | 0 |
![]() |
![]() |
Korea Investment Partners | 0 | 0 | 0 |
![]() |
![]() |
Mirae Asset Venture Investment | 0 |
![]() |
![]() |